Tablet sales increased by 19% to DKK 677 million, while SCIT/SLIT-drops sales increased by 3% to DKK 522 million. Sales of other products were down 3% to DKK 146 million. EBIT increased to DKK 194 million on higher sales, improved gross margin and efficiencies.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AKBLF:
- ALK and McMaster researchers discover new cell that remembers allergies
- AKBLF Upcoming Earnings Report: What to Expect?
- ALK’s 2030 CO2 reduction targets have been approved by SBTi
- Release date of annual report 2023 for ALK and webcast
- ALK’s European registration application for house dust mite SLIT-tablet in young children accepted for review